Inactive Instrument
Celladon Corp Stock Nasdaq
Stocks
US15117E1073
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 12.59M 10.78M 10.09M 9.23M 17.33M 1.2B 17.56M 119M 46.48M 605M 47.26M 46.23M 2B | P/E 2022 |
-0.51x | P/E 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 27.95M 23.94M 22.4M 20.5M 38.48M 2.67B 38.99M 265M 103M 1.34B 105M 103M 4.44B | EV / Sales 2022 |
-836,796x | EV / Sales 2023 | 1,605,487x |
| Free-Float |
86.47% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -4.91% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 59 | 18/04/2022 | |
Douglas Staut
PRN | Corporate Officer/Principal | - | 19/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.91% | -10.06% | - | - | 12.59M | |
| +1.09% | +3.39% | +3.50% | +25.49% | 51.22B | |
| -1.07% | +2.82% | +474.18% | +601.24% | 45.38B | |
| +1.44% | +7.77% | +19.27% | +90.94% | 41.97B | |
| +1.47% | +9.79% | +40.15% | +21.21% | 42.15B | |
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | |
| -0.60% | +1.93% | - | - | 16.73B | |
| +1.32% | +7.30% | +36.93% | +152.36% | 17.1B | |
| +0.03% | +3.91% | +5.84% | +35.04% | 14.76B | |
| +1.28% | +5.41% | +91.01% | +46.93% | 13.91B | |
| Average | -0.10% | +3.19% | +86.03% | +127.48% | 30.58B | |
| Weighted average by Cap. | +0.46% | +3.13% | +103.46% | +149.23% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 13.48 11.55 10.81 9.89 18.57 1.29K 18.81 127.69 49.79 648.1 50.63 49.53 2.14K | 15.77 13.51 12.64 11.57 21.72 1.51K 22 149.36 58.25 758.12 59.23 57.94 2.51K |
| Net income | -96.78M -82.9M -77.57M -71M -133M -9.26B -135M -916M -357M -4.65B -363M -355M -15.39B | -74.96M -64.21M -60.08M -55M -103M -7.17B -105M -710M -277M -3.6B -281M -275M -11.92B |
| Net Debt | -63.29M -54.22M -50.73M -46.44M -87.15M -6.06B -88.3M -599M -234M -3.04B -238M -232M -10.06B | 15.36M 13.16M 12.31M 11.27M 21.15M 1.47B 21.43M 145M 56.72M 738M 57.67M 56.42M 2.44B |
Employees
-
